The Gross Margin of Kiniksa Pharmaceuticals Ltd (KNSA) is 85.61%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 85.61% |
| 2023-12-31 | 87.64% |
| 2022-12-31 | 89.60% |
| 2021-12-31 | 76.39% |
| 2020-12-31 | 76.39% |